Literature DB >> 22676909

Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II.

Takehiro Michikawa1, Manami Inoue, Norie Sawada, Motoki Iwasaki, Yasuhito Tanaka, Taichi Shimazu, Shizuka Sasazuki, Taiki Yamaji, Masashi Mizokami, Shoichiro Tsugane.   

Abstract

OBJECTIVE: The purpose of the present study was to develop a risk estimation model for the 10-year risk of hepatocellular carcinoma (HCC) that could be easily used in a general population to aid in the prevention of HCC.
METHODS: Our prediction model was derived from data obtained on 17,654 Japanese aged 40 to 69 years who participated in health checkups (follow-up: 1993-2006). Cox proportional hazards regression was applied to obtain coefficients for each predictor.
RESULTS: During follow-up, a total of 104 cases of HCC were newly diagnosed. After checking the model fit, we incorporated age, sex, alcohol consumption, body mass index, diabetes, coffee consumption, and hepatitis B and C virus infection into the prediction model. The model showed satisfactory discrimination (Harrell's c-index=0.94) and was well calibrated (the overall observed/expected ratio=1.03, 95% confidence interval=0.83-1.29). We also developed a simple risk scoring system. Those subjects with total scores of 17 or more under this system (score range: -1 to 19) had an estimated 10-year HCC risk of over 90%; those with 4 points or less had an estimated risk of less than 0.1%.
CONCLUSION: We developed a simple 10-year risk prediction model for HCC in the Japanese general population as a public education tool.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22676909     DOI: 10.1016/j.ypmed.2012.05.017

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  15 in total

Review 1.  Surveillance of the Patients with High Risk of Hepatocellular Cancer.

Authors:  Necati Örmeci
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 2.  Liver cancer screening in high-risk populations.

Authors:  Morris Sherman
Journal:  Hepat Oncol       Date:  2015-11-30

3.  Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.

Authors:  Hui-Chen Wu; Hwai-I Yang; Qiao Wang; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

4.  Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.

Authors:  Jennifer A Flemming; Ju Dong Yang; Eric Vittinghoff; W Ray Kim; Norah A Terrault
Journal:  Cancer       Date:  2014-07-16       Impact factor: 6.860

5.  Neighborhood deprivation and risk of cancer incidence, mortality and survival: results from a population-based cohort study in Japan.

Authors:  Yasuhiro Miki; Manami Inoue; Ai Ikeda; Norie Sawada; Tomoki Nakaya; Taichi Shimazu; Motoki Iwasaki; Taiki Yamaji; Shizuka Sasazuki; Kenji Shibuya; Shoichiro Tsugane
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

6.  HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus.

Authors:  Lingling He; Shuan Zhang; Xiaoli Liu; Yuyong Jiang; Xianbo Wang; Zhiyun Yang
Journal:  J Diabetes Res       Date:  2017-01-05       Impact factor: 4.011

7.  Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.

Authors:  Tsai-Chung Li; Chia-Ing Li; Chiu-Shong Liu; Pao-Hsuan Lin; Wen-Yuan Lin; Chih-Hsueh Lin; Sing-Yu Yang; Jen-Huai Chiang; Cheng-Chieh Lin
Journal:  Oncotarget       Date:  2017-10-10

8.  Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.

Authors:  Talita Duarte-Salles; Sandeep Misra; Magdalena Stepien; Amelie Plymoth; David Muller; Kim Overvad; Anja Olsen; Anne Tjønneland; Laura Baglietto; Gianluca Severi; Marie-Christine Boutron-Ruault; Renee Turzanski-Fortner; Rudolf Kaaks; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Valeria Pala; Domenico Palli; Amalia Mattiello; Rosario Tumino; Alessio Naccarati; H B As Bueno-de-Mesquita; Petra H Peeters; Elisabete Weiderpass; J Ramón Quirós; Antonio Agudo; Emilio Sánchez-Cantalejo; Eva Ardanaz; Diana Gavrila; Miren Dorronsoro; Mårten Werner; Oskar Hemmingsson; Bodil Ohlsson; Klas Sjöberg; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Marc J Gunter; Amanda J Cross; Elio Riboli; Mazda Jenab; Pierre Hainaut; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2016-06-23

9.  Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study.

Authors:  Chansik An; Jong Won Choi; Hyung Soon Lee; Hyunsun Lim; Seok Jong Ryu; Jung Hyun Chang; Hyun Cheol Oh
Journal:  BMC Cancer       Date:  2021-06-29       Impact factor: 4.430

10.  Risk prediction models for hepatocellular carcinoma in different populations.

Authors:  Xiao Ma; Yang Yang; Hong Tu; Jing Gao; Yu-Ting Tan; Jia-Li Zheng; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.